Mycophenolate Interactions
Mycophenolate Interactions is a pharmacological construct that refers to the modulation of mycophenolic acid's pharmacokinetics or pharmacodynamics by concomitantly administered agents, particularly in the context of immunosuppressive regimens in transplant recipients, thereby affecting drug efficacy, toxicity, or therapeutic outcomes.
14
Publications
563
Citations
98
Authors
37
Institutions
Publications per year
2017–2026
1
14
Serge Cremers, Rik C. Schoemaker, Eduard M. Scholten et al. · British Journal of Clinical Pharmacology · 2005 · 90 citations · Full text
1–5 of 14
98
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 98
37
GlaxoSmithKline (France)
Villebon-sur-Yvette, France
1 h-index
2 publications
102 citations

LMU Klinikum
Munich, Germany
1 h-index
7 publications
434 citations

Brigham and Women's Hospital
Boston, United States
1 h-index
1 publications
20 citations
Zimmer Biomet (Germany)
Berlin, Germany
1 h-index
1 publications
30 citations
GlaxoSmithKline (United States)
Philadelphia, United States
1 h-index
1 publications
51 citations
University of Fukui Hospital
Fukui-shi, Japan
1 h-index
3 publications
87 citations
University of Michigan
Ann Arbor, United States
1 h-index
7 publications
280 citations

Amsterdam UMC Location University of Amsterdam
Amsterdam, The Netherlands
1 h-index
1 publications
90 citations
1–8 of 37
2 publications · 54 citations
2
h-index
1 publications · 30 citations
1
h-index
1 publications · 29 citations
1
h-index
CID · 1 publications · 20 citations
1
h-index
1 publications · 33 citations
1
h-index
1–5